PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Feb-2025 e-therapeutics to Present Preclinical Data on ETX-148 at EAHAD 2025 e-therapeutics
05-Feb-2025 OPEN Health Appoints David Sakadelis as Chief Technology Officer OPEN Health
05-Feb-2025 Liva Healthcare acquires Momenta, and secures funding from new and existing investors to drive growth Liva Healthcare
05-Feb-2025 Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO Thermo Fisher Scientific
05-Feb-2025 Viromed Medical AG: Successful placement of shares with a strategic investor in the healthcare industry to accelerate market entry in Europe Viromed Medical AG
05-Feb-2025 FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness Roche
05-Feb-2025 Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region Formycon AG
04-Feb-2025 SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items SCHOTT Pharma AG & Co. KGaA
04-Feb-2025 Lundbeck announces changes to the Board of Directors Lundbeck
04-Feb-2025 Enduro Genetics raises €12 million to unlock the future of scalable bioproduction Enduro Genetics
04-Feb-2025 Ninety-Nine Percent of Life Sciences and High-Tech Leaders Expect AI to Drive Revenue Management Value in 2025 Model N
04-Feb-2025 Evolva Holding SA: Shareholder Clearway requests general meeting Evolva Holding SA
04-Feb-2025 Novartis Kisqali® (ribociclib) receives MHRA authorisation for the adjuvant treatment of HR+/HER2- early breast cancer at high risk of recurrence in a broad population of patients Novartis
04-Feb-2025 New Data Presented at the International Stroke Conference Further Validates Treatment Impact of Brainomix 360 Brainomix
04-Feb-2025 Servier to Adopt Veeva RIM to Streamline and Advance its Global Regulatory Operations Veeva Systems
04-Feb-2025 Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America Ardena
04-Feb-2025 Immunic to Participate in Investor and Scientific Conferences in February Immunic AG
04-Feb-2025 Eleva and 3PBIOVIAN Sign Strategic GMP Manufacturing and Technology Alliance to Boost Capacity for Eleva’s Platform and Pipeline Eleva
04-Feb-2025 ACI Group expands offering with Orcas Naturals to meet growing demand for Ayurvedic and Botanical Ingredients ACI Group
04-Feb-2025 Aplagon Announces EUR 7 Million Financing to Advance its APAC Therapeutic for Thrombo-Inflammatory Diseases into Phase 2A Clinical Trials Aplagon